The Public Partners of Westleaf
Westleaf Inc (TSXV: WL) is a $300 million company in which we can almost guarantee you have never heard about. Distinctly western in nature, it pulls at our prairie roots here at The Deep Dive, enticing us to look deeper at this firm that is new to the public markets scene. Debuting on the TSX […]
Cannara Biotech & Its Ties to FSD Pharma
Cannara Biotech (CSE:LOVE) is set to start trading today under the ticker symbol LOVE on the Canadian Securities Exchange. As a result of this event, we thought it fitting to provide some coverage to the equity given its connections to fan favourite FSD Pharma. Similar to FSD Pharma, there are many misconceptions and exaggerations floating […]
EastWest Biosciences: The Investment Thesis
EastWest Biosciences (TSXV: EAST) was recently selected by our viewers to be the next company in focus here at The Deep Dive. In the early stages of its execution, EastWest Biosciences has begun to develop a loyal following of investors eager to learn more on the company. In an effort to tackle this hunger, we […]